[Foot tumor and diffuse pain: a case of oncogenic osteomalacia]

Ann Pathol. 2005 Apr;25(2):134-7. doi: 10.1016/s0242-6498(05)86176-0.
[Article in French]

Abstract

Oncogenic osteomalacia is a rare clinicopathologic entity, linked to a mesenchymal tumor which overexpresses a hypophosphatemic factor, supposed to be the FGF-23. To date, about 100 cases have been published. We report the case of a 40-year-old man who presented an osteomalacic syndrome with no classical etiological diagnosis. The discovery of a subcutaneous tumor of the right foot and a high serum level of FGF-23 suggested the diagnosis of oncogenic osteomalacia. Surgical removal of the tumor resulted in complete reversal of the clinical and biochemical defects. Pathologic examination revealed spindle cells associated with osteoclast-like giant cells, embedded within a myxoid matrix which showed floculent calcification. These observations were compatible with the features of PMTMCT (Phosphaturic mesenchymal tumor mixed connective tissue variant).

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Cell Division
  • Diagnosis, Differential
  • Fibroblast Growth Factor-23
  • Foot Diseases / pathology*
  • Foot Diseases / physiopathology*
  • Humans
  • Male
  • Osteoclasts / pathology
  • Osteomalacia / pathology*
  • Osteomalacia / physiopathology
  • Pain
  • Syndrome